Alterations of DNA damage response pathway:Biomarker and therapeutic strategy for cancer immunotherapy

被引：12

作者：

Minlin Jiang ^{[1
,2
]}

Keyi Jia ^{[1
,2
]}

Lei Wang ^{[1
]}

Wei Li ^{[1
]}

Bin Chen ^{[1
]}

Yu Liu ^{[1
,2
]}

Hao Wang ^{[1
,2
]}

Sha Zhao ^{[1
]}

Yayi He ^{[1
]}

Caicun Zhou ^{[1
]}

机构：

[1] Department of Medical Oncology, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University School of Medicine

[2] Medical School, Tongji University

来源：

Acta Pharmaceutica Sinica B | 2021年 / 11卷 / 10期

基金：

中国国家自然科学基金;

关键词：

D O I：

暂无

中图分类号：

R730.51 [免疫疗法];

学科分类号：

100214 ;

摘要：

Genomic instability remains an enabling feature of cancer and promotes malignant transformation. Alterations of DNA damage response(DDR) pathways allow genomic instability, generate neoantigens, upregulate the expression of programmed death ligand 1(PD-L1) and interact with signaling such as cyclic GMPe AMP synthase-stimulator of interferon genes(cGASe STING) signaling. Here, we review the basic knowledge of DDR pathways, mechanisms of genomic instability induced by DDR alterations, impacts of DDR alterations on immune system, and the potential applications of DDR alterations as biomarkers and therapeutic targets in cancer immunotherapy.

引用

页码：2983 / 2994

页数：12

共 50 条

[21] Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer
Curtin, N. J.
BRITISH JOURNAL OF PHARMACOLOGY, 2013, 169 (08) : 1745 - 1765
[22] Therapeutic targeting of the DNA damage response in prostate cancer
Marshall, Catherine H.
Antonarakis, Emmanuel S.
CURRENT OPINION IN ONCOLOGY, 2020, 32 (03) : 216 - 222
[23] Potential DNA Repair Biomarker for Response to Immunotherapy of Lung Cancer Patients
Livneh, Z.
Paz-Elizur, T.
Leitner-Dagan, Y.
Meyer, K.
Markus, B. Barak
Giorgi, F.
O'Reilly, M.
Kim, H.
Evgy, Y.
Rintoul, R. C.
Ponder, B.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S447 - S448
[24] Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer
Kim, Isaac E., Jr.
Kim, Sinae
Srivastava, Arnav
Saraiya, Biren
Mayer, Tina
Kim, Wun-Jae
Kim, Isaac Yi
BMC UROLOGY, 2019, 19 (1)
[25] Similar incidence of DNA damage response pathway alterations between clinically localized and metastatic prostate cancer
Isaac E. Kim
Sinae Kim
Arnav Srivastava
Biren Saraiya
Tina Mayer
Wun-Jae Kim
Isaac Yi Kim
BMC Urology, 19
[26] The Landscape of Alterations in DNA Damage Response Pathways in Colorectal Cancer
Arai, Hiroyuki
Elliott, Andrew
Xiu, Joanne
Wang, Jingyuan
Battaglin, Francesca
Kawanishi, Natsuko
Soni, Shivani
Zhang, Wu
Millstein, Joshua
Sohal, Davendra
Goldberg, Richard M.
Hall, Michael J.
Scott, Aaron J.
Khushman, Moh'd
Hwang, Jimmy J.
Lou, Emil
Weinberg, Benjamin A.
Marshall, John L.
Lockhart, Albert C.
Stafford, Phillip
Zhang, Jian
Moretto, Roberto
Cremolini, Chiara
Korn, W. Michael
Lenz, Heinz-Josef
CLINICAL CANCER RESEARCH, 2021, 27 (11) : 3234 - 3242
[27] Impact of DNA damage response defects in cancer cells on response to immunotherapy and radiotherapy
Czajkowski, Daniel
Szmyd, Radoslaw
Gee, Harriet E.
JOURNAL OF MEDICAL IMAGING AND RADIATION ONCOLOGY, 2022, 66 (04) : 546 - 559
[28] DNA DAMAGE RESPONSE PATHWAY ALTERATIONS AND DEFICIENCY IN SARCOMAS IN CHILDREN AND YOUNG ADULTS
Statz-Geary, Kurt
Bialick, Steven
Serrano, Cesar
Elliott, Andrew
Walker, Phillip
Abraham, Jim
Amato, GinaD'
Von Mehren, Margaret
Trent, Jonathan
Rosenberg, Andrew
Montgomery, Elizabeth
Dhir, Aditi
PEDIATRIC BLOOD & CANCER, 2022, 69 : S325 - S326
[29] The DNA damage response in immunotherapy and radiation
Samstein, Robert M.
Riaz, Nadeem
ADVANCES IN RADIATION ONCOLOGY, 2018, 3 (04) : 527 - 533
[30] DNA Damage Response Gene Alterations and their Association with Tumor Mutation Burden and Response to Immunotherapy in NSCLC and SCLC
Li, Z.
Niu, Y.
Ma, T.
Yuan, H.
JOURNAL OF THORACIC ONCOLOGY, 2021, 16 (03) : S182 - S182

← 1 2 3 4 5 →